甲状腺激素对急性A型主动脉夹层患者术后急性肾损伤的影响及预后价值
该回顾性研究纳入2021年1月至2023年12月在南京医科大学附属南京医院重症医学科治疗的176例急性A型主动脉夹层术后患者,按是否发生AKI分为AKI组与非AKI组,按是否发生非甲状腺疾病综合征(NTIS)分为NTIS组与非NTIS组。AKI发生率为59.7%(105例),其中1期46例(26.1%)、2期32例(18.2%)、3期27例(15.3%);NTIS发生率为64.2%(113例)。NTIS组术后第1、3、5天SCr水平、总体AKI发生率及2期和3期AKI发生率均高于非NTIS组(均P<0.05)。FT3、TT3、FT4、TT4随AKI分期加重而下降(均P<0.05)。FT3、TT3及术后第1天SCr预测院内死亡的AUC分别为0.770(95%CI 0.636-0.904)、0.812(95%CI 0.708-0.916)、0.719(95%CI 0.597-0.840),三者联合AUC最高为0.838(95%CI 0.732-0.944)。
要点
- ATAAD术后AKI发生率59.7%(105/176),其中1期26.1%、2期18.2%、3期15.3%。
- NTIS发生率64.2%(113/176),NTIS组术后第1、3、5天SCr、总体AKI及2期和3期AKI发生率均高于非NTIS组(均P<0.05)。
- FT3、TT3、FT4、TT4随AKI分期加重而下降(均P<0.05),TSH随AKI分期加重轻度升高(P>0.05)。
- FT3、TT3联合术后第1天SCr预测院内死亡AUC为0.838(95%CI 0.732-0.944),高于三者单独预测。
- AKI组较非AKI组BMI更高,血管活性药和强心药使用比例、肺部感染和NTIS发生率、输血、再次手术及CRRT比例更高,预测死亡率和实际死亡率更高,总住院时间和ICU住院时间更长(均P<0.05)。
适用人群与场景
- 2021年1月至2023年12月在南京医科大学附属南京医院重症医学科接受治疗的急性A型主动脉夹层术后患者。
- 共纳入176例术后ATAAD患者。
诊断标准与关键阈值
- 根据术后是否发生急性肾损伤分为AKI组与非AKI组。
- 根据是否发生非甲状腺疾病综合征(NTIS)分为NTIS组与非NTIS组。
- AKI分期:1期46例(26.1%)、2期32例(18.2%)、3期27例(15.3%)。
研究设计与关键结果
- 回顾性研究,纳入176例ATAAD术后患者,AKI发生105例(59.7%),NTIS发生113例(64.2%)。
- 非AKI组NTIS发生率为54.9%(39/71),1期、2期、3期AKI患者NTIS发生率分别为56.5%(26/46)、84.4%(27/32)、77.8%(21/27)。
- AKI组较非AKI组BMI更高,血管活性药和强心药使用比例、肺部感染和NTIS发生率、输血、再次手术及CRRT比例更高,预测死亡率和实际死亡率更高,总住院时间和ICU住院时间更长,FT3、TT3、FT4水平更低(均P<0.05)。
- NTIS组术后第1、3、5天SCr水平、总体AKI发生率及2期和3期AKI发生率均高于非NTIS组(均P<0.05)。
- FT3、TT3、FT4、TT4随AKI分期加重而下降(均P<0.05),TSH随AKI分期加重轻度升高(P>0.05)。
- FT3、TT3及术后第1天SCr预测院内死亡的AUC分别为0.770(95%CI 0.636-0.904)、0.812(95%CI 0.708-0.916)、0.719(95%CI 0.597-0.840);三者联合AUC最高为0.838(95%CI 0.732-0.944)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为FT3和FT4水平下降可能参与AKI的发生和进展,甲状腺激素水平越低,AKI越重、预后越差。
- 作者认为FT3和TT3联合术后第1天SCr可作为ATAAD患者院内死亡的辅助预测指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between changes in serum thyroid hormone levels and postoperative acute kidney injury (AKI) as well as the severity of AKI in patients with acute type A aortic dissection (ATAAD), and to evaluate their predictive value for in-hospital mortality.
METHODS: A retrospective study was conducted. Patients who underwent surgery for ATAAD and received treatment in the Department of Intensive Care Medicine of Nanjing Hospital Affiliated to Nanjing Medical University from January 2021 to December 2023 were enrolled. General information, thyroid function, biochemical indicators, blood routine, procalcitonin, coagulation function and other data were collected. Patients were divided into AKI group and non-AKI group based on whether AKI occurred after surgery. In addition, patients were divided into NTIS group and non-NTIS group based on whether they developed non-thyroidal illness syndrome (NTIS). The factors associated with AKI and the impact of thyroid hormone levels on the stage of AKI were analyzed. The predictive value of thyroid hormone and serum creatinine (SCr) for in-hospital mortality was analyzed using the receiver operator characteristic curve (ROC curve).
RESULTS: A total of 176 postoperative ATAAD patients were enrolled. AKI occurred in 105 patients (59.7%), including 46 cases (26.1%) of stage 1 AKI, 32 cases (18.2%) of stage 2 AKI, and 27 cases (15.3%) of stage 3 AKI. NTIS occurred in 113 patients (64.2%), the incidence of NTIS in the non-AKI group and in patients with stage 1, stage 2, and stage 3 AKI was 54.9% (39/71), 56.5% (26/46), 84.4% (27/32), and 77.8% (21/27), respectively. Compared with the non-AKI group, the AKI group had higher body mass index, proportion of vasopressors and cardiac stimulants used, incidence of pulmonary infection and NTIS, blood transfusion, reoperation, and continuous renal replacement therapy (CRRT), higher predicted mortality and actual mortality, as well as longer total hospital stay and the length of intensive care unit stay, and lower levels of free tri-iodothyronine (FT3), total tri-iodothyronine (TT3), and free thyroxine (FT4), and there were statistically significant differences in SCr, uric acid, blood sodium, alanine transaminase, aspartate transaminase, creatine kinase, MB isoenzyme of creatine kinase, white blood cell count, procalcitonin, platelet count, prothrombin time, activated partial thromboplastin time, and fibrinogen between the two groups (all P<0.05). The NTIS group had higher postoperative day 1, 3, and 5 SCr levels, overall AKI incidence, and incidences of stage 2 and stage 3 AKI than the non-NTIS group (all P<0.05). FT3, TT3, FT4, and total thyroxine (TT4) decreased with increasing severity of AKI stage (all P<0.05), while TSH slightly increased with increasing severity of AKI stage (P>0.05). ROC curve analysis showed that the area under the curve (AUC) and 95% confidence interval (95%CI) of FT3, TT3, and postoperative day 1 SCr for predicting in-hospital mortality were 0.770 (0.636-0.904), 0.812 (0.708-0.916), and 0.719 (0.597-0.840), respectively. The combination of the three had the highest AUC, which was 0.838 (0.732-0.944).
CONCLUSIONS: The incidence of AKI is relatively high in patients following ATAAD surgery. The decline in FT3 and FT4 levels may contribute to the occurrence and progression of AKI. The lower the thyroid hormone levels, the more severe AKI and the worse the prognosis. FT3 and TT3 combined with postoperative day 1 SCr may serve as auxiliary predictors of in-hospital mortality in ATAAD patients.
参考来源
- Song S, Hong L, Zou L, et al. [The impact and prognostic value of thyroid hormones on postoperative acute kidney injury in patients with acute type A aortic dissection]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42281542. doi:10.3760/cma.j.cn121430-20250927-00496
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。